K5 Therapeutics (SRL)

Active

VAT

BE 0757.718.072

Address

Gaston Geenslaan 3

3001 Leuven

Established

02-11-2020

Principal activity

Research and experimental development on biotechnology

Try for free

Crisis resilience of K5 Therapeutics

Which companies are best armed against current economic trends and the energy crisis?

2023		2022		2021
Turnover	-	-	€1,752,970	-	-
Profit/Loss	€124,322	-86%	€885,725	203%	-€862,881
Equity	€2,509,566	5%	€2,385,244	59%	€1,499,519
Gross margin	€1,359,753	11%	€1,224,339	279%	-€685,397
Employees	10,6 FTE	293%	2,7 FTE	238%	0,8 FTE

Publications in the Belgian Official Journal for K5 Therapeutics

Type	Date	Pdf	Subject
	22-11-2022		Registered Office (NL)
	20-07-2022		Registered Office (NL)
	20-07-2021		Miscellaneous - Resignations - Appointments (NL)
	14-07-2021		Articles of Association (Translation, Coordination, Other Modifications, …) - Resignations - Appoint… (NL)
	20-05-2021		Miscellaneous (FR)

Sources

Frequently asked questions

What is the VAT number of K5 Therapeutics?

The VAT number of K5 Therapeutics is BE0757718072.

When was K5 Therapeutics founded?

K5 Therapeutics was founded on 02-11-2020.

What is the address of K5 Therapeutics?

The current registered office of K5 Therapeutics is located at Gaston Geenslaan 3, 3001 Leuven.

When was the last time K5 Therapeutics filed their annual financial statements?

The most recent financial statements of K5 Therapeutics were filed on 26-06-2024. You can view them here.

How many employees does K5 Therapeutics have?

There are 10,6 FTEs working at K5 Therapeutics according to the staff figures in the most recent financial statements.

What is the annual turnover of K5 Therapeutics?

At the time of its most recent financial statements, K5 Therapeutics did not publish any turnover figures. K5 Therapeutics reported a gross margin of €1,359,752.50.